Homeopathy 2009; 98(04): 186-197
DOI: 10.1016/j.homp.2009.09.009
Copyright © The Faculty of Homeopathy 2009

Inhibition of basophil activation by histamine: a sensitive and reproducible model for the study of the biological activity of high dilutions

J. Sainte-Laudy
1   CHU, Limoges 87042, France
Ph Belon
2   CRDT, 45 cours A Briand, 69300 Caluire, France
› Author Affiliations

Subject Editor:
Further Information

Publication History

Received08 July 2009
revised21 September 2009

accepted23 September 2009

Publication Date:
20 December 2017 (online)

Background: At the beginning of this series of experiments we were looking for a model based on the use of purified commercially available compounds based on a fully described and accepted pharmacological model to study of the biological effect of high dilutions. Negative feedback induced by histamine, a major pro-inflammatory mediator, on basophils and mast cells activation via an H2 receptor me these criteria. The simplest way of measuring basophil activation in the early 1980's was the human basophil activation test (HBDT).

Objectives: Our major goal was first to study the biological effect of centesimal histamine dilutions beyond the Avogadro limit, on the staining properties of human basophils activated by an allergen extract initially house dust mite, then an anti-IgE and N-formyl-Met-Leu-Phe (fMLP). Technical development over the 25 years of our work led us to replace the manual basophil counting by flow cytometry. The main advantages were automation and observer independence. Using this latter protocol our aim was to confirm the existence of this phenomenon and to check its specificity by testing, under the same conditions, inactive analogues of histamine and histamine antagonists. More recently, we developed an animal model (mouse basophils) to study the effect of histamine on histamine release.

Methods and results: For the HBDT model basophils were obtained by sedimentation of human blood taken on EDTA and stained with Alcian blue. Results were expressed in percentage activation. Histamine dilutions tested were freshly prepared in the lab by successive centesimal dilutions and vortexing. Water controls were prepared in the same way. For the flow cytometric protocol basophils were first labeled by an anti-IgE FITC (basophil marker) and an anti-CD63 (basophil activation marker). Results were expressed in percentage of CD63 positive basophils. Another flow cytometric protocol has been developed more recently, based on basophil labeling by anti-IgE FITC (fluorescein isothiocyanate) and anti-CD203 PE (another human basophil activation marker). Results were expressed in mean fluorescence intensity of the CD203c positive population (MFI-CD203c) and an activation index calculated by an algorithm. For the mouse basophil model, histamine was measured spectrofluorimetrically.

The main results obtained over 28 years of work was the demonstration of a reproducible inhibition of human basophil activation by high dilutions of histamine, the effect peaks in the range of 15–17CH. The effect was not significant when histamine was replaced by histidine (a histamine precursor) or cimetidine (histamine H2 receptor antagonist) was added to the incubation medium. These results were confirmed by flow cytometry. Using the latter technique, we also showed that 4-Methyl histamine (H2 agonist) induced a similar effect, in contrast to 1-Methyl histamine, an inactive histamine metabolite.

Using the mouse model, we showed that histamine high dilutions, in the same range of dilutions, inhibited histamine release.

Conclusions: Successively, using different models to study of human and murine basophil activation, we demonstrated that high dilutions of histamine, in the range of 15–17CH induce a reproducible biological effect. This phenomenon has been confirmed by a multi-center study using the HBDT model and by at least three independent laboratories by flow cytometry. The specificity of the observed effect was confirmed, versus the water controls at the same dilution level by the absence of biological activity of inactive compounds such as histidine and 1-Methyl histamine and by the reversibility of this effect in the presence of a histamine receptor H2 antagonist.

  • References

  • 1 Sainte-Laudy J, Belon P, Halpern G. Homeopathy. Effect of histaminum on “in vitro” basophil degranulation. Abstract of XI International Congress of Allergology and Clinical Immunology 1982: 338
  • 2 Sainte-Laudy J., Cherruault Y., Papapanaotou C. Analyse mathématique et modélisation du test de dégranulation (TDBH). Bio-Sciences 1987; 5 (06) 210-214.
  • 3 Belon P. Modelization of the effect of Hahnemannian dilutions on human basophil degranulation. Proceedings of the Seventh International Congress of Cybernetic and Systems, London 1987: 7–11.
  • 4 Papanaotou C, Guellal S, Cherruault Y, Belon P, Sainte-Laudy J. Mathematical Analysis and Modelling in Homeopathy. Proceedings of the Seventh international Congress of Cybernetics and Systems, London 1987: 18–23.
  • 5 Cherruault Y., Guillez A., Sainte-Laudy J., Belon P. Etude mathématique et statistique des effets de dilutions successives de chlorhydrate d'histamine sur la réactivité des basophiles humains. Bio-Sciences 1988; 7: 63-72.
  • 6 Poitevin B., Davenas E., Benveniste J. Modulation of the in vitro degranulation of human basophils by lung histamine and Apis mellifica . Homeopath Fr 1988; 76 (03) 167-175.
  • 7 Poitevin B., Davenas E., Benveniste J. In vitro immunological degranulation of human basophils is modulated by lung histamine and Apis mellifica . Br J Clin Pharmac 1988; 25: 439-444.
  • 8 Davenas E., Beauvais F., Amara J. et al. Human basophil degranulation triggered by very dilute antiserum against IgE. Nature 1988; 333: 816-818.
  • 9 Coles P. Benveniste controversy rages on in the French press. Nature 1988; 334 (6181): 372
  • 10 When to publish pseudo-science. Nature 1988; 334 (6181): 367
  • 11 Explanation of Benveniste. Nature 1988; 334 (6180): 285-286.
  • 12 Pool R. Unbelievable results spark a controversy. Science 1988; 241 (4864): 407
  • 13 Cherruault Y., Guillez A., Sainte-Laudy J., Belon P. Etudes mathématiques et statistiques des effets de dilutions successives de chlorhydrate d'histamine sur la réactivité des basophiles humains. Bio-sciences 1989; 7: 63-72.
  • 14 Sainte-Laudy J., Sambucy J.L., Belon P. Biological activity of ultra low doses of histamine on human basophil degranulation triggered by D. pteronyssinus extract. Ultra Low Dose. 1991. Taylor & Francis Ltd; 127-138
  • 15 Sainte-Laudy J., Belon P. Biological activity of ultra low doses II/effect of ultra low doses of histamine on human basophil degranulation triggered by Anti-IGE. Ultra Low Doses. 1991. Taylor & Francis; 139-143
  • 16 Sainte-Laudy J., Belon P. Inhibition of human basophil activation by high dilutions of histamine. Agents Actions 1993; 38: C245-C247.
  • 17 MacGlashan Jr. D. Granulocytes: new roles for basophils. Immunol Cell Biol 2008; 86 (08) 637-638.
  • 18 Iliopoulos O., Baroody F.M., Naclerio R.M. et al. Histamine-containing cells obtained from the nose hours after antigen challenge has functional and phenotypic characteristics of basophils. J Immunol 1992; 148 (07) 2223-2228.
  • 19 Guo C.B., Liu M.C., Galli S.J. et al. Identification of IgE-bearing cells in the late-phase response to antigen in the lung as basophils. Am J Respir Cell Mol Biol 1994; 10 (04) 384-390.
  • 20 McGlashan Jr. D.W. Releasability of human basophils: cellular sensitivity and maximal histamine release are independent variables. J Allergy Clin Immunol 1993; 91 (02) 605-615.
  • 21 Pruzansky J.J., Petterson R. Binding constants of IgE receptors on human blood basophils for IgE. Immunology 1986; 58: 257-262.
  • 22 Knol E.F., Mul F.P., Jansen H., Calafat J., Roos D. Monitoring human basophil activation via CD63 antibody 435. J Allergy Clin Immunol 1991; 88: 328-338.
  • 23 Sainte-Laudy J., Vallon C., Guerin J.C. Analysis of membrane expression of the CD63 human basophil activation marker. Applications to allergologic diagnosis. Allerg Immunol 1994; 26: 211-214.
  • 24 Sainte-Laudy J., Sabah A., Vallon C., Guerin J.C. Analysis of anti-IgE and allergen induced human basophil activation by flow cytometry, comparison with histamine release. Inflamm Res 1998; 47 (10) 401-408.
  • 25 Sainte-Laudy J., Sabbah A., Vallon C., Guerin J.C. Analysis of anti-IgE and allergen induced human basophil activation by flow cytometry. Comparison with histamine release. Inflamm Res 1998; 47: 401-408.
  • 26 Sainte-Laudy J., Sabbah A., Drouet M. et al. Diagnosis of venom allergy by flow cytometry. Correlation with clinical history, skin test, specific IgE, histamine and leukotriene C4 release. Clin Exp Allergy 2000; 30: 1166-1171.
  • 27 Crockard A.D., Ennis M. Laboratory-based allergy diagnosis; should we go with the flow?. Clin Exp Allergy 2001; 31: 957-977.
  • 28 Moneret-Vautrin D.A., Sainte-Laudy J., Kanny G. et al. Human basophil activation meaured by CD63 expression and LTC4 release in IgE-mediated food allergy. Ann Allergy Asthma Immunol 1999; 82: 33-40.
  • 29 Ebo D.G., Sainte-Laudy J., Bridts C.H. et al. Flow-assisted allergy diagnosis. Application and future perspectives. Allergy 2006; 61: 1028-1039.
  • 30 Abuaf N., Rajoely B., Gaouar H., Pecquet C., Leynadier F. Flow cytometry in the diagnosis of allergy. Rev Fr Allergol 2004; 44: 37-44.
  • 31 Sanz M., Gamboa P.M., Antepara I. Flow cytometric basophil activation by detection of CD63 expression in patients with immediate-type reactions to betalactam antibiotics. Clin Exp Allergy 2002; 32: 277-286.
  • 32 MacGlashan Jr. D., Lichtenstein L.M. Studies of antigen binding on human basophils. I. Antigen binding and functional consequences. J Immunol 1983; 130 (05) 2330-2336.
  • 33 Buhring J., Streble A., Valent P. The basophil-specific ectoenzyme E-NNP3 (CD203c) as a marker for cell activation and allergy diagnosis. Int Arch Allergy Immunol 2004; 133: 317-329.
  • 34 Hennersdorf F., Florian S., Jakob A. et al. Identification of CD13, CD107a, and CD164 as novel basophil-activation markers and dissection of two response patterns in time kinetics of IgE-dependent upregulation. Cell Res 2005; 15: 325-335.
  • 35 Sainte-Laudy J., Boujedaini N., Belon P. Differential effect of storage on molecular and ultra-molecular dilutions of histamine. Inflamm Res 2009; 58 (Suppl. 01) 30-31.
  • 36 Lichtenstein L.M., Gillespie E. The effects of the H1 and H2 antihistamines on “allergic” histamine release and its inhibition by histamine. J Pharmacol Exp Ther 1975; 192: 441-450.
  • 37 Lichtentstein L.M., Gillistie E. Inhibition of histamine release by histamine controlled by H2 receptors. Nature 1973; 244: 287-288.
  • 38 Masini E., Blandina P., Brunelleschi S., Mannaioni P.F. Evidence for H2-receptor-mediated inhibition of histamine release from isolated rat mast cells. Agents Actions 1982; 12: 85-88.
  • 39 Sainte-Laudy J., Belon P. Etude pharmacologique de dilutions hahnemanniennes sur la dégranulation des basophiles humains. Fondation Francaise pour la Recherche en Homeopathie (sous l'égide de la Fondation de France) Recherches en Homeopathie 1986: 41-58
  • 40 Belon P., Cumps J., Ennis M. et al. Inhibition of human basophil degranulation by successive histamine dilutions: results of a European multi-centre trial. Inflamm Res 1999; 48 (Suppl. 01) S17-S18.
  • 41 Belon P., Cumps J., Ennis M. et al. Histamine dilutions modulate basophil activation. Inflamm Res 2004; 53: 1-8.
  • 42 Sainte-Laudy J., Belon P. Inhibition of human basophil activation by high dilutions of histamine. Agents Actions 1993; 38: C245-C247.
  • 43 Sainte-Laudy J., Belon P. Analysis of immunosuppressive activity of serial dilutions of histamine on human basophil activation by flow cytometry. Inflamm Res 1996; 45 (Suppl. 01) S33-S34.
  • 44 Sainte-Laudy J. Modulation of allergen and anti-IgE induced human basophil activation by serial histamine dilutions. Inflamm Res 2000; 49 (Suppl. 01) S5-S6.
  • 45 Sainte-Laudy J., Belon P. Application of flow cytometry to the analysis of the immunosuppresive effects of histamine dilutions on human basophil activation: effects of cimetidine. Inflamm Res 1997; 46: S27-S28.
  • 46 Rey L.R. Thermoluminescence of ultra-high dilutions of lithium chloride and sodium chloride. Physica A 2003; 323: 67-74.
  • 47 Sainte-Laudy J., Belon P. Improvement of flow cytometric analysis of basophil activation inhibition by high histamine dilutions. Interest of a novel basophil specific marker: the CD 203c. Homeopathy 2006; 95 (01) 3-8.
  • 48 Sainte-Laudy J., Belon P. Use of four different flow cytometric protocols for the analysis of human basophil activation. Application to the study of the biological activity of high dilutions of histamine. Inflammation Research 2006; 55 (Suppl. 01) S23-S24.
  • 49 Sainte-Laudy J., Boujedaini N., Belon P. Confirmation of biological effects of high dilutions. Effects of submolecular concentrations of histamine and of 1-, 3- and 4-methylhistamines on human basophil activation. Inflamm Res 2008; 57 (Suppl. 01) S27-S28.
  • 50 Schneider E., Machavoine F., Pleau J.M. et al. Organic transporter 3 modulates murine basophil fonctions by controlling intracellular histamine levels. J Exp Med 2005; 202 (03) 387-393.
  • 51 Kremzner L.T., Wilson J.B. A procedure for the determination of histamine. Biochim Biophys Acta 1961; 50: 364-367.
  • 52 Shore P.A., Burkhalter A., Cohn Jr. V.H. A method for the fluorometric assay of histamine in tissues. J Pharmacol Exp Ther 1959; 127: 182-186.
  • 53 Ovelgönne J.H., Bol A.W.J.M., Hop W.C.J., Van Wijk R. Mechanical agitation of very dilute antiserum against IgE has no effect on basophil staining properties. Experientia 1992; 48: 504-508.
  • 54 Hirst S.J., Hayes N.A., Burridge J., Pearce F.L., Foreman J.C. Human basophil degranulation is not triggered by very dilute antiserum against human IgE. Nature 1993; 366: 525-527.
  • 55 Benveniste J., Davenas E. et al. L'agitation de solutions hautement diluées n'induit pas d'activité biologique spécifique. Paris, série II C.R Acad Sci 1991; 312: 461-466.
  • 56 Brown V., Ennis M. Flow-cytometric analysis of basophil activation: inhibition by histamine at conventional and homeopathic concentrations. Inflamm Res 2001; 50 (Suppl. 02) S47-S48.
  • 57 Lorentz I., Schneider E.M., Stolz P., Brack A., Strube J. Sensitive flow cytometric method to test basophil activation influenced by homeopathic histamine dilutions. Forsh Kompletärmed Klass Natruheilkd 2003; 10: 316-324.
  • 58 Chirumbolo S, Brizzi M, Ortolani R, Vella A and Bellavite P. Inhibition of CD203c membrane up-regulation in human basophils by high dilutions of histamine: a controlled replication study. Inflamm Res. Doi:10.1007/s00011-009-0044-4.
  • 59 Guggisberg A.G., Baumgartner S.M., Tschopp C.M., Heusser P. Replication study concerning the effects of homeopathic dilutions of histamine on human basophil degranulation in vitro . Complement Ther Med 2005; 13 (02) 91-100.
  • 60 Shekarchi I.C., Sever J.L., Lee Y.J., Castellano G., Madden D.L. Evaluation of various plastic microtiter plates with measles, toxoplasma and gamma globulin antigens in enzyme-linked immunosorbent assays. J Clin Microbiol 1984; 19: 89-96.
  • 61 Doutremepuich C.H., Aguejouf O., Belon P. Effects of ultra-low dose aspirin on embolization in a model of laser-induced thrombus formation. Semin Thromb Hemost 1996; 22 (Suppl. 01) 67-70.
  • 62 Doutremepuich C., de Seze O., Anne M.C., Hariveau E., Quilichini R. Platelet aggregation on whole blood after administration of ultra low dosage acetylsalicylic acid in healthy volunteers. Thromb Res Suppl 1987; 47 (03) 373-378.
  • 63 Lalanne M.C., Doutremepuich C., de Seze O., Belon P. What is the effect of acetylsalicylic acid at ultra low dose on the interaction platelets/vessel wall?. Thromb Res Suppl 1990; 60 (03) 231-236.
  • 64 Eizayaga F.X., Aguejouf O., Desplat V., Belon P., Doutremepuich C. Modification produced by selective inhibitors of cyclooxygenase and ultra low dose aspirin on platelet activity in portal hypertension. World J Gastroenterol 2007; 13 (38) 5065-5070.
  • 65 Doutremepuich C., Aguejouf O., Eizayaga F.X., Desplat V. Reverse effect of aspirin: is the prothrombic effect after the aspirine discontiuation mediated by cyclooxygenase 2 inhibition?. Pathophysiol Haemost Thromb 2007; 36 (01) 40-44.
  • 66 Cazin J.C., Cazin M., Gaborit J.L. et al. A study of the effects of decimal and centesimal dilutions of arsenic on the retention and mobilization of arsenic in the rat. Hum Exp Toxicol 1987; 6 (04) 315-320.
  • 67 Belon P., Banerjee P., Choudhury S.C. et al. Administration of potentized homeopathic remedy. Arsenicum album, after anti-nuclear antibody (ANA) titer in people living in high-risk arsenic contaminated area? I. A correlation with certain haematological parameters. Ecam 2006; 3 (01) 99-107.
  • 68 Khuda-Bukhsh A.R. Towards understanding molecular mechanism of action of homeopathic drugs: an overview. Mol Cell Biochem 2003; 253 (01/02) 339-345.
  • 69 Lipardi C., Wei Q., Paterson B. siRNA converts mRNA into dsRNAs that are degraded to gerate new siRNAs. Cell 2001; 107: 297-307.
  • 70 Harborth J., Elbashir S.M., Bechert K., Tuschl T., Weber K. Identification of essential genes in cultures mammalian cells using small interfering RNAs. J Cell Sci 2001; 114: 4557-4565.
  • 71 Rey L.R. Low temperature thermoluminescence. Nature 1998; 391: 418
  • 72 Rey L.R. Thermoluminescence de la glace. CR Acad Sci Paris Physique 2000; 1: 107-110.
  • 73 Elia V., Niccoli M. New physico-chemical properties of extremely diluted aqueous solutions. J Thermal Anal Calorimetry 2004; 75: 815-836.
  • 74 Elia V., Elia L., Cacace P., Napoli E., Niccoli M., Savarese F. Extremely dilute solutions as multi-variable systems. A study of calorimetric and condutometric behaviour as function of the parameter time. J Therm Anal Calorim 2006; 84 (02) 317-323.
  • 75 Demangeat J.L. NMR water proton relaxation in unheated and heated ultrahigh aqueous dilutions of histamine: evidence for an air-dependent supramolecular organization of water. L Mol Liquids 2008; 10: 10-16.
  • 76 Roy R., Tiller W., Bell I.R., Hoover M.R. The structure of liquid water. Novel insight from materials research; potential relevance to homeopathy. Mat Res Innov 2005; 9: 98-103.